SPRO - Spero Therapeutics Inc
IEX Last Trade
1.365
-0.005 -0.366%
Share volume: 58,378
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.37
-0.01
-0.37%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Cash flow financing | |
| Other financing cash flows | |
| Cash flow | |
| Net income | |
| Depreciation | |
| Changes in inventories | |
| Changes in receivables | |
| Investing Cashflow | |
| Net Borrowings | |
| Investing Activity Other | |
| Dividends Paid | |
| Exchange Rate Effect | |
| Capital Expenditures | |
| Cash Change |